Friday, January 20, 2023

New vaccine for Covid now in trials

A new made-in-Canada COVID-19 vaccine that can be inhaled is set to enter Phase 2 human trials.

[...]

The vaccine is meant to target parts of the coronavirus that do not change or mutate, potentially making it more effective against new variants.

"The current vaccination strategy for COVID-19 has us constantly chasing the virus, and it’s clear that we simply can’t keep up," explained Matthew Miller, scientific director of McMaster's infectious disease research institute, and one of the trial's leaders. "Our team has developed a vaccine strategy aimed at circumventing this cycle and the need to constantly update these vaccines by targeting parts of the virus that are resistant to mutation, and inducing strong immunity at the site where infection actually occurs."

  CTV

No comments: